002864SZSE

Announcement on the Resolutions of the 2025 Annual Shareholders' Meeting

Panlong Pharmaceutical Co., Ltd.··15 pages

✨ AI Summary

The announcement details the resolutions passed during the 2025 Annual Shareholders' Meeting of Shanxi Panlong Pharmaceutical Group Co., Ltd. Key decisions include the approval of the 2025 Board Work Report, profit distribution plans, and the termination of certain investment projects. All proposals were approved with significant majority votes, ensuring compliance with relevant laws and regulations.

Summary generated by AI · Always verify with source document

Exchange Summary

AGM RESOLUTION

The Company held its Annual General Meeting of 2025 on 26 May 2026, during which the following proposal(s) was/were approved: 1. 2025 work report of the board of directors 2. 2025 profit distribution plan 3. Authorization to the board to decide on the interim profit distribution plan 4. Confirmation of 2025 remuneration for directors and 2026 remuneration plan 5. Appointment of 2026 audit firm 6. Termination of some projects financed with raised funds 7. Repurchase and cancellation of all restricted stocks 8. Amendments to the Company's articles of association 9. Amendments to and formulation of the Company's some governance systems 9.1. The Company's rules of procedure governing shareholders' general meetings 9.2. The Company's rules of procedure governing the board meetings 9.3. Work system for independent directors 9.4. Information disclosure management system 9.5. Raised funds management system 9.6. Management system for online voting system at shareholders' general meetings 9.7. Implementing rules for cumulative voting system 9.8. Investor relation management system 9.9. Remuneration management system for directors and senior management 10. 2026 stock option incentive plan (draft) and its summary 11. Appraisal management measures for the implementation of 2026 stock option incentive plan 12. Authorization to the board to handle matters regarding the 2026 stock option incentive plan 13. The first phase employee stock ownership plan (draft) and its summary 14. Management measures for the first phase employee stock ownership plan 15. Authorization to the board to handle matters regarding the first phase employee stock ownership plan The detailed profit distribution plan is as follows: 1) Cash dividend/10 shares (tax included): CNY2.50000000 2) Bonus issue from profit (share/10 shares): none 3) Bonus issue from capital reserve (share/10 shares): 3.000000

Provided by Shenzhen Stock Exchange

Full Translation

AI Translation· azure_openai

Shanxi Panlong Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or major omissions.

Special Reminder:

  1. There were no rejected proposals at this shareholders' meeting.
  2. This shareholders' meeting involved changes to resolutions previously approved by past shareholders' meetings.

On September 25, 2024, the Company held its second extraordinary shareholders' meeting of 2024, where it reviewed and approved the proposal regarding the Company's intended purchase of land use rights and investment in the construction of the Panlong Life Science Industrial Park. This shareholders' meeting resolved to terminate the purchase of land use rights and investment in the construction of the Panlong Life Science Industrial Park.

1. Meeting Time and Attendance

  1. Meeting Time:

    • On-site meeting date: May 26, 2026 (Tuesday) at 14:00.
    • Online voting time: Specific times for online voting through the Shenzhen Stock Exchange trading system are from 9:15-9:25, 9:30-11:30, and 13:00-15:00 on May 26, 2026; voting through the Shenzhen Stock Exchange internet voting system can occur at any time from 9:15 to 15:00 on May 26, 2026.

  2. Meeting Location:

    • Conference Room, 2nd Floor, Shanxi Panlong Pharmaceutical Co., Ltd., No. 2801, Bayliu 2nd Road, Modern Textile Industrial Park, Baqiao District, Xi'an City.

  3. Voting Method:

    • The meeting adopted a combination of on-site voting and online voting.

  4. Convener:

    • The Board of Directors.

  5. Chairman of the Meeting:

    • Mr. Xie Xiaolin, Chairman.

  6. Compliance:

    • The convening and holding of this meeting comply with the relevant provisions of the Company Law of the People's Republic of China, the Shenzhen Stock Exchange Listing Rules, the Self-Regulatory Guidelines for Listed Companies No. 1, and the Company's Articles of Association.

  7. Attendance:

    • A total of 161 shareholders attended the meeting through on-site and online voting, representing 40,465,438 shares, accounting for 38.2083% of the total shares with voting rights. Among them, 7 shareholders attended the meeting in person, representing 38,383,832 shares (36.2428%), and 154 shareholders voted online, representing 2,081,606 shares (1.9655%).
    • Small and medium-sized shareholders: 153 small and medium-sized shareholders attended the meeting, representing 1,996,706 shares (1.8853%). Among them, 1 small and medium-sized shareholder voted in person, representing 100 shares (0.0001%), and 152 voted online, representing 1,996,606 shares (1.8852%).
    • All directors and the board secretary attended the meeting, and other senior management personnel were present. Lawyers from Beijing Ruqiang Law Firm witnessed the meeting and issued a legal opinion.

2. Proposal Review and Voting Results

The shareholders' meeting adopted a combination of on-site voting and online voting, with the specific voting results as follows:

  1. Proposal on the 2025 Board Work Report:

    • Total voting results: 40,355,438 shares in favor (99.7282%), 97,000 shares against (0.2397%), 13,000 shares abstained (including 1,600 shares default abstained due to non-voting, 0.0321%).
    • Small and medium-sized shareholders: 1,886,706 shares in favor (94.4909%), 97,000 shares against (4.8580%), 13,000 shares abstained (including 1,600 shares default abstained due to non-voting, 0.6511%).
    • This proposal was approved.

  2. Proposal on the 2025 Profit Distribution and Capital Reserve Fund Conversion Plan:

    • Total voting results: 40,265,338 shares in favor (99.5055%), 96,700 shares against (0.2390%), 103,400 shares abstained (including 100,400 shares default abstained due to non-voting, 0.2555%).
    • Small and medium-sized shareholders: 1,796,606 shares in favor (89.9785%), 96,700 shares against (4.8430%), 103,400 shares abstained (including 100,400 shares default abstained due to non-voting, 5.1785%).
    • This proposal is a special resolution and was approved by more than two-thirds of the valid voting shares held by shareholders present at the meeting.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing